FilingSEC EDGAR8-KAN2 Therapeutics, Inc. filed Form 8-KJun 4, 2026, 16:15 ET · SEC acceptedSummaryFiling infoView sourceFiling contentPlease check the source for details.Related companiesAN2 Therapeutics, Inc.ANTXView stockLikeCommentsRepostShareComments —CommentLoading comments…
Comments —
Loading comments…